Early and accurate assessment of skin lesions is critical in dermatology, yet clinicians are often required to make high-stakes decisions under time pressure. The ability to assess a lesion quickly and confidently can make a meaningful difference in patient outcomes.

DermEngine is redefining this process by delivering real-time feedback powered by artificial intelligence, helping clinicians make more informed decisions at the point of care. Through its Visual Search feature, clinicians can quickly assess the risk of similar images using advanced image analysis, supporting faster, more confident clinical decisions from the very first evaluation.

Real-Time Insight, Right When It’s Needed

Traditional lesion assessment often involves a combination of visual inspection, dermoscopic analysis, and, when uncertainty remains, a biopsy or referral. DermEngine accelerates this workflow by offering real-time feedback as soon as a lesion image is captured or uploaded. Within seconds, clinicians can receive statistics of the most similar images, allowing them to quickly gauge the level of concern associated with a lesion.

This is DermEngine’s Visual Search feature, an AI-driven tool designed to provide immediate insight into whether a lesion is more likely to be benign or malignant. Rather than replacing clinical judgment, Visual Search acts as a powerful decision-support system, enhancing a clinician’s ability to triage lesions efficiently and consistently.

This immediacy is especially valuable in busy clinical environments, teledermatology settings, or primary care practices where dermatology expertise may be limited. Real-time AI feedback helps clinicians prioritize high-risk lesions, reduce unnecessary delays, and make more confident next-step decisions.

Powered by the World’s Largest Dermatology Image Database

The Visual Search feature leverages the largest dermatology image database in the world, containing a vast and diverse collection of clinically validated images. Each new lesion image is compared against this database to identify visual similarities across a wide range of benign and malignant conditions.

By learning from millions of examples, the AI can detect subtle visual patterns that may be difficult to recognize with the naked eye alone. This comparison-based approach allows Visual Search to make a malignancy risk assessment that's grounded in real-world clinical data, not theoretical models.

Supporting Better Clinical Decisions

DermEngine’s real-time AI feedback is designed to support—not override—clinical expertise. The malignancy risk assessment provides an additional layer of insight, helping clinicians decide whether a lesion can be monitored, requires further imaging, or should be biopsied or referred. This can lead to more consistent triage decisions, reduced variability between providers, and improved patient communication.

For patients, real-time feedback can also ease anxiety. Clinicians are better equipped to explain their assessment and rationale during the visit, rather than waiting days or weeks for follow-up results.

What real-time feedback delivers in review

In AI-assisted lesion review, real-time feedback translates into practical benefits:

• Speed: less time scanning large image sets manually
• Focus: attention directed to areas most likely to matter
• Consistency: more repeatable review across clinicians and visits
• Confidence: clearer triage and fewer “did I miss something?” moments
• Better longitudinal care: easier evaluation of change over time
  
  

Conclusion

DermEngine’s real-time AI feedback is transforming how clinicians evaluate skin lesions by bringing speed, data, and intelligence directly into the clinical workflow. As dermatology continues to evolve, DermEngine’s real-time AI capabilities represent a major step forward—bringing intelligence, speed, and precision exactly where they’re needed most.

-The MetaOptima Team

Thanks for reading! Curious about how DermEngine can improve your practice?